UNODC/CND/EG.1/2010/13 28 July 2010 Original: English Item ...€¦ · Vienna, 11-13 October 2010...

UNODC/CND/EG.1/2010/13

28 July 2010 Original: English

V.10-55614 (E)

*1055614*

Expert group on data collection Vienna, 11-13 October 2010 Item 3 of the provisional agenda* Finalization of the content and structure of a revised, simple and efficient reporting system

Revised draft annual report questionnaire: Part Four. Extent, patterns and trends in drug cultivation, manufacture and trafficking

Note by the Secretariat

__________________

* UNODC/CND/EG.1/2010/9.

2 V.10-55614


Revised draft annual report questionnaire

Part Four. Extent, patterns and trends in drug cultivation, manufacture and trafficking

Report of the Government of _______________________________

Reporting year _______________________________

Completed on (date) _______________________________

Please return completed questionnaire to: [email protected]

The completed revised draft annual report questionnaire is due on: [date].

For technical support, contact:

Telephone Fax E-mail UNODC Vienna 1 800 123 456 1 800 654 321 [email protected] Regional offices: [list]

Note This is a printable version of the revised draft annual report questionnaire, which is in the form of an Excel spreadsheet and is designed to be completed electronically. In this printable version, definitions of key terms used in the questionnaire are provided in the footnotes, whenever relevant; in the electronic version, these definitions (and additional instructions) are repeated throughout the questionnaire through the “Comments” function in Excel. The Excel spreadsheet also uses drop-down lists for some questions, allowing respondents to simply select from a list the answer that is most appropriate for their country.

V.10-55614 3


Instructions

The revised draft annual report questionnaire consists of the following four parts:

Part One. Legislative and institutional framework

Part Two. Comprehensive approach to drug demand and supply reduction

Part Three. Extent, patterns and trends in drug use

Part Four. Extent, patterns and trends in drug cultivation, manufacture and trafficking

This is part four of the revised draft annual report questionnaire.

Respondents are asked to complete all questions. Where no data are available, this should be indicated by inserting two dashes (--) or writing “don’t know” in the appropriate cell. All questions refer to the reporting year, unless otherwise indicated.

Respondents

Countries are invited to identify a single focal point for reporting data on drugs. In exceptional and duly justified cases, respondents may identify technical contacts who may contribute to completing the questionnaire, indicating, if possible, which questions they contributed to.

Metadata

Respondents may refer to multiple sources in completing the revised draft annual report questionnaire. These sources may include published reports and/or data sets not in the public domain, including routinely collected data from treatment, law enforcement or other agencies. All sources referred to during the completion of the questionnaire should be listed in the section on metadata, which can be found at the end of each section of the questionnaire. This information helps UNODC to understand the information provided.

About the questions

In recognition of the fact that not all countries have detailed data on all of the topics covered in the questionnaire, part four of the revised draft annual report questionnaire asks for quantitative information and information about experts’ perceptions of the situation and trends.

Quantitative data or estimates

These questions ask for quantitative data or estimates. The revised draft annual report questionnaire includes standardized response categories but, should the data available not conform to those categories, they can still be included. Simply indicate the categories used (e.g. age range, drug category) in the space provided. Quantitative data or estimates should be provided for the reporting year. Where this is not possible, please include the most appropriate recent figures available. The year in which the data were collected should always be specified. If national data or estimates are not available, the data or an estimate for a part of the country or for a sub-group of the population can be indicated. If more than one such partial dataset or estimate is available, the data or estimate that is believed to be the best

4 V.10-55614


alternative for recent national data or estimates should be used. In such cases, the geographical or population coverage of the data or estimate should be specified as simply but as explicitly as possible; similarly, the size of the reference population should also be specified, if relevant.

Several questions relate to classes or types of drugs. Whenever applicable, it is important that the information requested be about individual drugs. Although care has been taken to include all major drugs, the pre-coded lists might not fully match the needs of every country. Therefore, in each list the opportunity has been provided to add other classes or types of drugs. These open categories can also be used to insert alternative groups of drugs. For example, some questions list “heroin” and “other illicit opioids”; if the only information available is on opioids in general (no types are specified), “any opioids” should be listed under “other drugs”.

V.10-55614 5


Technical notes

Prescription drugs (containing substances under international control)

Below are some examples of substances that fall within a certain category of prescription drugs that contain controlled substances and can be diverted or counterfeit. A full list of prescription drugs within each category, providing both the chemical and the most common proprietary names, is available from www.unodc.org.

Category of prescription drugs Examples Prescription opioids Buprenorphine (e.g. Subutex), codeine,

dextropropoxyphene, fentanyl, hydrocodone (e.g. Vicodin), hydromorphone, methadone, morphine, oxycodone (e.g. Oxycontin), pethidine and suboxone.

Prescription stimulants Amfepramone, fenetylline, methylphenidate, pemoline, phenmetrazine, phentermine.

Benzodiazepines Alprazolam (e.g. Xanax), clonazepam (e.g. Rivantril and Rivotril), diazepam (e.g. Valium), flunitrazepam (e.g. Rohypnol) and temazepam.

Barbiturates Allobarbital, barbital, phenobarbital, pentobarbital and secbutabarbital

6 V.10-55614


Classes and types of drugs under international control (narcotic drugs and psychotropic substances)

Listed below are the classes and types of drugs included in the revised draft annual report questionnaire. In some cases, examples of particular drug types are provided, but the lists of these examples are not exhaustive.

Class of drug Type of drug Any illicit drug Cannabis Marijuana (herb)a

Hashish (resin)b Plants Oil Seeds Other types of cannabis

Opioids Heroin Opium Illicit morphine Poppy plants Poppy seeds Diverted/counterfeit prescription drugs containing opioids under international control Other illicit opioids (e.g. “homebake”)

Cocaine Salts (cocaine hydrochloride (HCl), powder cocaine) “Crack” Coca leaf Other types of cocaine (e.g. coca paste, cocaine paste, cocaine base, basuco, paco and merla)

Amphetamine-type stimulantsc

Amphetamine Methamphetamine “Ecstasy”-type substances (e.g. MDMA, MDA, MDE/MDEA)d Diverted/counterfeit prescription drugs containing amphetamine-type stimulants Other stimulants (e.g. methcathinone, 4-MTA, 2C-B, MDBD)

Sedatives and tranquillisers

Diverted/counterfeit prescription drugs containing benzodiazepines Diverted/counterfeit prescription drugs containing barbiturates Methaqualone Gamma-hydroxybutyric acid (GHB) Other sedatives and tranquillisers

Hallucinogens Lysergic acid diethylamide (LSD) Other hallucinogens (e.g. phencyclidine (PCP), mushrooms with psychoactive properties, tryptamines)

Solvents and inhalants

Drugs under national but not international control

Including khat, piperazines (e.g. N-benzylpiperazine (BZP)), tramadol and ketamine, depending on national legislation.

a The flowering or fruiting tops of the cannabis plant (excluding the seeds and leaves when not accompanied by the tops) from which the resin has not been extracted.

b The separated resin, whether crude or purified, obtained from the cannabis plant. c Stimulants placed under international control in the Convention on Psychotropic Substances of 1971 (United Nations, Treaty Series,

vol. 1019, No. 14956). d MDA=methylenedioxyamphetamine; MDEA=3,4-methylenedioxyethylamphetamine; MDMA=methylenedioxymethamphetamine.


7V.10-55614

Res

pond

ents

Inst

ruct

ions

Pr

ovid

e de

tails

of

the

foca

l po

int f

or r

epor

ting

of d

rug

data

in y

our

coun

try.

In

the

exce

ptio

nal c

ases

in w

hich

te

chni

cal

cont

acts

hav

e be

en i

dent

ifie

d, y

ou m

ay w

ish

to l

ist

them

in

the

tabl

e en

title

d “a

dditi

onal

tec

hnic

al

cont

acts

”, in

dica

ting,

if p

ossi

ble,

whi

ch q

uest

ions

they

hav

e co

ntri

bute

d to

.

Foca

l poi

nt

Nam

e Po

siti

on

Age

ncy

Phon

e Fa

x E

-mai

l

Add

ition

al te

chni

cal c

onta

cts

(opt

iona

l)

N

ame

Posi

tion

A

genc

y Te

leph

one

Fax

E-m

ail

Que

stio

ns

cont

ribu

ted

to

Exam

ple

Mr.

John

Sm

ith

Chi

ef

Stat

istic

ian

Offi

ce o

f Dru

g C

ontr

ol

+44

221

657

3 +

44 2

21 6

001

j.sm

ith@

odc.

gov

6-9

and

10-1

3

Con

trib

utor

#1

Con

trib

utor

#2

Con

trib

utor

#3

Con

trib

utor

#4

Con

trib

utor

#5

8 V.10-55614


Trafficking

Class and type of drugs Question 1 2 3

What is the total quantity of drugs seized in your country in the reporting

year?a

What is the total

number of drug

seizures carried out

in the reporting year?c, d

What definition of “drug seizures” were used

in answering questions 1 and 2? Preferred unit:

kilograms Preferred time frame:

reporting year Time frame used: ______________

Other unit of quantityb

Quantity Unit Number of Units

Type of Unit

Example 112.5 kilograms 10,000 tablets 279 Cannabis Marijuana (herb) Hashish (resin) Plant Oil Seeds Other types of cannabis (specify) ____________________________

Illicit opioids Heroin Opium (raw and prepared) Illicit morphine Diverted/counterfeit prescription drugs

containing opioids under international control (specify)

____________________________

Other illicit opioids (specify) ____________________________ Cocaine Salts (cocaine HCl, powder cocaine) “Crack” Coca leaf Other types of cocaine (specify) ____________________________

Amphetamine-type stimulants (total)e Amphetamine Methamphetamine “Ecstasy”-type substances Diverted/counterfeit prescription

amphetamine-type stimulants

Other stimulants (specify) ____________________________ Sedatives and tranquillisers (total)e Diverted/counterfeit prescription drugs

containing benzodiazepines

Diverted/counterfeit prescription drugs containing barbiturates

Methaqualone GHB Other sedatives and tranquillisers

(specify) _________________________

V.10-55614 9


Hallucinogens (total)e LSD Other hallucinogens (specify) ____________________________ Solvents and inhalants (specify) ______________________

Drugs under national but not international control (specify)

____________________________ ____________________________ ____________________________ Other (specify) ____________________________ All drugs (grand total) a Include both retail and wholesale seizures. Each seizure should be counted only once. b A unit can be a tablet, a capsule, an ampoule, a tab etc. c A seizure case involving more than one drug type should be counted under each specific drug type involved. When available, the

totals per drug class (cannabis, opioids, cocaine etc.) should be provided, as well as the grand total (in the cell for “all drugs”). d Where applicable and if possible, please include seizures made outside the territory of your country by law enforcement agencies of

your country (such as seizures in international waters), but only the seizures that have not been entrusted to, retained by or otherwise disposed of by agencies of another country.

e Data for each drug type are preferable. If data are not available for each drug type, provide aggregate data for each class of drug (e.g. amphetamine-type stimulants, hallucinogens).

Metadata What sources of information (published and unpublished) were referred to in answering these questions?

10 V.10-55614


Trafficking*

Note: Questions 4-6 refer to drugs seized in your country during the reporting period. If additional countries are required, please provide these in an attachment.

Class and type of drugs Question Origin Transit Final destination

4 (a) 4 (b) 5 6

Producing/ manufacturing countrya

Country of departure

List the country from which the drug entered

your countryb

List the main countries to which the drug was

destined Cannabis Main

countriesc Percentaged Main

countriese Main countries

Percentagef Main countriesg

Percentageh

Marijuana (herb) 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Hashish (resin) 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Oil 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Other types of cannabis (specify)

1. 2. 3

1. 2. 3.

1. 2. 3.

1. 2. 3

1. 2. 3.

1. 2. 3.

1. 2. 3.

Opioids Heroin 1.

2. 3

1. 2. 3.

1 2 3.

1. 2. 3

1. 2. 3.

1. 2. 3.

1. 2. 3.

Opium 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Illicit morphine 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Prescription drugs containing opioids under international control (specify)

1. 2. 3

1. 2. 3.

1. 2. 3.

1. 2.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Other illicit opioids (specify)

1. 2. 3.

1. 2. 3.

1. 2. 3

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Cocaine Salts (cocaine HCl, powder

cocaine) 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

“Crack”

1. 2. 3

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Other types of cocaine (specify)

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Amphetamine-type stimulants Amphetamine 1.

2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

__________________

* “Trafficking” refers to the movement of illicit drugs or precursor materials across international borders.

V.10-55614 11


Methamphetamine 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

“Ecstasy”-type substances 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Counterfeit/diverted prescription drugs containing amphetamine-type stimulants (specify)

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Other stimulants (specify)

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Sedatives and tranquillisers (specify)

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Hallucinogens LSD 1.

2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Other (specify) 1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.


1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

Other (specify)

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

1. 2. 3.

a For marijuana, cannabis resin, opium and coca leaf, please list the country of production; for other drugs, such as heroin and cocaine, please list the country of manufacture, not cultivation.

b Please consider the last country through which the drugs transited before reaching your country. This could be a neighbouring country, if the drugs were transported by land, or any other country, if drugs were transported by air.

c List the main countries where the drug was cultivated or manufactured. d Indicate the percentage of all seizures (by weight) produced or manufactured in that country. The percentages may not add up to 100 per

cent since only information on the three main countries is requested. e List the main countries (by weight of drug seized) that were the point of departure for drug traffickers, or unaccompanied shipments of

drugs, reaching your country. The drugs may or may not be produced/manufactured in these countries. Please do not include your own country.

f Indicate the percentage of all seizures (by weight) entering your country that came through the main countries indicated. The percentages may not add up to 100 per cent since only information on the three main countries is requested.

g Your own country may be included. h Indicate the percentage of seizures (by weight) destined for each country. The percentages may not add up to 100 per cent since only

information on the three main countries is requested.



12 V.10-55614

Traf

ficki

ng

Cla

ss a

nd ty

pe o

f dru

gs

Que

stio

n

7 (a

) 7

(b)

8

Inbo

und

Out

boun

d

W

hat p

erce

ntag

e of

sei

zure

s (b

y w

eigh

t) th

at c

ame

into

you

r co

untr

y in

th

e re

port

ing

year

was

bei

ng

tran

spor

ted

by e

ach

met

hod?

Wha

t per

cent

age

of s

eizu

res

(by

wei

ght)

th

at le

ft y

our

coun

try

in th

e re

port

ing

year

was

bei

ng tr

ansp

orte

d by

eac

h m

etho

d?

Wha

t has

bee

n th

e tr

end

in

traf

fick

ing

of e

ach

drug

ove

r th

e re

port

ing

year

?a

A

ir

Lan

d Se

a M

ail

A

ir

Lan

d Se

a M

ail

Large increase

Some increase

Stable

Some decrease

Large decrease

Don’t know

All

illic

it d

rugs

=1

00%

=1

00%

C

anna

bis

=100

%

=1

00%

M

ariju

ana

(her

b)

=100

%

=100

%

H

ashi

sh (r

esin

)

=1

00%

=1

00%

Oil

=1

00%

=1

00%

Oth

er (s

peci

fy)

__

____

____

____

____

____

__

=100

%

=100

%

O

pioi

ds

=100

%

=1

00%

H

eroi

n

=1

00%

=1

00%

Opi

um

=100

%

=100

%

Ill

icit

mor

phin

e

=1

00%

=1

00%

Div

erte

d/co

unte

rfei

t pre

scri

ptio

n dr

ugs

cont

aini

ng o

pioi

ds u

nder

inte

rnat

iona

l co

ntro

l (sp

ecif

y)

__

____

____

____

____

____

__

=100

%

=100

%

Oth

er (s

peci

fy)

__

____

____

____

____

____

__

=100

%

=100

%

C

ocai

ne

=100

%

=1

00%

Sa

lts (c

ocai

ne H

Cl,

pow

der c

ocai

ne)

=100

%

=100

%

“C

rack

”

Oth

er (s

peci

fy)

__

____

____

____

____

____

__

=100

%

=100

%

A

mph

etam

ine-

type

sti

mul

ants

=1

00%

=100

%

Am

phet

amin

e

=1

00%

=1

00%

Met

ham

phet

amin

e

=1

00%

=1

00%

“Ecs

tasy

”-ty

pe s

ubst

ance

s

=1

00%

=1

00%

Div

erte

d/co

unte

rfei

t pre

scri

ptio

n dr

ugs

cont

aini

ng a

mph

etam

ine-

type

stim

ulan

ts

=100

%

=100

%

O

ther

stim

ulan

ts

=100

%

=100

%

Se

dati

ves

and

tran

quill

iser

s (s

peci

fy)

__

____

____

____

____

____

____

__

=100

%

=100

%


13V.10-55614

Hal

luci

noge

ns

=100

%

=1

00%

LS

D

=100

%

=100

%

O

ther

(spe

cify

)

____

____

____

____

____

____

=1

00%

=1

00%

Dru

gs u

nder

nat

iona

l but

not

in

tern

atio

nal c

ontr

ol (s

peci

fy)

__

____

____

____

____

____

____

__

=100

%

=100

%

__

____

____

____

____

____

____

__

=100

%

=100

%

__

____

____

____

____

____

____

__

=100

%

=100

%

Oth

er (s

peci

fy)

__

____

____

____

____

____

____

__

=1

00%

=1

00%

a “S

tabl

e” re

fers

to a

n es

timat

ed v

aria

tion

of u

nder

10

per c

ent;

“som

e in

crea

se”

and

“som

e de

crea

se”

refe

r to

an e

stim

ated

var

iatio

n of

bet

wee

n 10

and

25

per c

ent;

“lar

ge

incr

ease

” an

d “l

arge

dec

reas

e” re

fer t

o an

est

imat

ed v

aria

tion

of m

ore

than

25

per c

ent.

Met

adat

a W

hat s

ourc

es o

f inf

orm

atio

n (p

ublis

hed

and

unpu

blis

hed)

wer

e re

ferr

ed to

in a

nsw

erin

g th

ese

ques

tions

?

14 V.10-55614


Trafficking

9. In cases for which there was a significant change in drug trafficking trends (see question 7) or in drug seizures (see question 1) in the reporting year, provide details on those trends and state the suspected reasons. Also include any other information relevant to trafficking in your country. Remember to always specify the name of the drug or drugs involved.

10. Were there any significant changes in the methods of transportation or the origin, routes or final destinations of drugs trafficked in your country during the past year? If yes, briefly describe these changes for the classes of drugs listed below and state the suspected reasons.

Cannabis Opioids Cocaine Amphetamine-type

stimulants


V.10-55614 15


Price and purity

11. Does your country have a system in place to monitor the price of illicit drugs?

At the retail level1 At the wholesale level2

Yes, on a routine basis. Specify frequency:3______________________.

Yes, on an ad hoc basis. Specify circumstances under which this occurs:_____________________________.

Yes, on some other basis. Specify:________________________________.

No

Yes, on a routine basis.

Specify frequency:3 _____________________. Yes, on an ad hoc basis. Specify circumstances under

which this occurs:_______________________. Yes, on some other basis.

Specify: _______________________________. No

If the answer is yes, please describe in detail the methodology used to monitor the price of illicit drugs at the retail level.

If the answer is yes, please describe in detail the methodology used to monitor the price of illicit drugs at the wholesale level.

12. (a) Do authorities in your country have access to laboratory services for analysing narcotic drugs and psychotropic substances seized by law enforcement agencies?

Yes, they have access to laboratory facilities in the country

Yes, they have access to laboratory facilities in other countries for some samples

Yes, they have access to laboratory facilities in other countries for all samples

No

(b) Are the following services provided?

Identification of seized drugs Yes No

__________________

1 The level of an illicit drug market at which the drug is provided to consumers (users). 2 The level of an illicit drug market at which the drug is sold in bulk, to be sold on to consumers

at a later stage. 3 For example, monthly, quarterly, annual.

16 V.10-55614


Quantification of seized drugs (determination of purity)

Yes No

Characterization/chemical profiling of seized drugs to determine their origin or for linking samples (“forensic drugs intelligence”)

Yes No

Analysis of precursor chemicals Yes No

Investigation of clandestine laboratories Yes No

Other (please specify)

_______________________ Yes No

_______________________ Yes No

(c) Under what circumstances are seized illicit drugs subjected to forensic analysis in your country?

Seized illicit drugs are never subjected to forensic analysis

Seized illicit drugs are routinely subjected to forensic analysis

Seized illicit drugs are subjected to forensic analysis upon request from law enforcement or judicial authorities

Seized illicit drugs are subjected to forensic analysis on some other basis. Specify: ______________________________________________________________________________________________________________________

Note: Answer questions 13 and 14 only if illicit drug crops are cultivated in your country.

V.10-55614 17


Class and type of drugs

Question 13

Farm gate pricea

Indicate the average farm gate price and common range of farm gate prices for illicit plant-based drugs in your country

Indicate moisture content/purity (whichever is applicable) for the

price provided Currency used: ________________________ Common rangeb Average From To Unit Example $1 500 $1 000 $2 000 1 kilogram 40% moisture Opium Opium (wet)

Opium (dry) Coca type Coca leaf

Coca paste

Cocaine base Other plant-based drugs (specify)

_____________________

_____________________

_____________________

a The farm gate price is the price paid to the grower or producer of the plant or drug prior to processing or manufacture. It is the price of the first sale in the distribution chain.

b The common range is the range observed most of the time. For example, if the price is between $1,200 and $1,800 most of the time, that is the common range.

14. Was there any significant change in the farm gate price of plant-based drugs in your country during the past year, compared to the previous year? Specify the drug or drugs and provide an explanation.



18 V.10-55614

Pric

e an

d pu

rity

Dru

g cl

ass

and

type

Q

uest

ion

15

16

17

18

Pric

e at

who

lesa

le le

vela

Puri

ty a

t who

lesa

le le

vela

Pric

e at

ret

ail (

stre

et) l

evel

dPu

rity

at r

etai

l (st

reet

) le

veld

In

dica

te th

e ty

pica

l who

lesa

le

pric

eb and

the

com

mon

ran

gec o

f pr

ices

of d

rugs

traf

fick

ed in

you

r co

untr

y

Indi

cate

the

typi

cal

puri

tyb a

nd th

e co

mm

on

rang

ec of p

urit

y le

vels

of

drug

s tr

affi

cked

in y

our

coun

try

Indi

cate

the

typi

cal r

etai

l pr

iceb a

nd th

e co

mm

on r

ange

c of

pri

ces

of d

rugs

sol

d in

you

r co

untr

y

Indi

cate

the

typi

cal r

etai

l pu

rity

b and

the

com

mon

ra

ngec o

f pur

ity

leve

ls o

f dr

ugs

sold

in y

our

coun

try

C

urre

ncy

used

: ___

____

____

____

_

Cur

renc

y us

ed: _

____

____

____

Com

mon

ran

ge

Com

mon

ran

ge

Com

mon

ran

ge

C

omm

on r

ange

Typi

cal

From

To

U

nit

Typi

cal

From

To

Ty

pica

l Fr

om

To

Uni

t Ty

pica

l Fr

om

To

Exam

ple

150

000

100

000

200

000

kg

35%

30

%

50%

25

0 15

0 35

0 gr

am

15%

5%

40

%

Can

nabi

se

Mar

ijuan

a (h

erb)

Has

hish

(res

in)

O

il

O

ther

(spe

cify

)

____

____

____

____

____

_

O

pioi

ds

H

eroi

n (s

peci

fy)f

__

____

____

____

____

___

__

____

____

____

____

___

Opi

umg

Il

licit

mor

phin

e

Oth

er (s

peci

fy)

__

____

____

____

____

___

Coc

aine

Salts

(coc

aine

HC

l, po

wde

r coc

aine

)

C

ocai

ne b

ase

“C

rack

”

O

ther

(spe

cify

)

____

____

____

____

____

_

A

mph

etam

ine-

type

st

imul

ants

A

mph

etam

ine

pow

der

A

mph

etam

ine

tabl

eth

(mg

per t

able

t)


19V.10-55614

M

etha

mph

etam

ine

pow

der/

cry

stal

line

M

etha

mph

etam

ine

tabl

eth

(mg

per t

able

t)

“E

csta

sy”-

type

sub

stan

ces

pow

der

“E

csta

sy”-

type

sub

stan

ces

tabl

eth (m

g pe

r tab

let)

O

ther

(spe

cify

)

____

____

____

____

____

_

Se

dati

ves

and

tran

quill

iser

s (s

peci

fy)

__

____

____

____

____

___

Hal

luci

noge

ns

LS

D

O

ther

(spe

cify

)

____

____

____

____

____

_

So

lven

ts a

nd in

hala

nts

(spe

cify

)

____

____

____

____

____

Dru

gs u

nder

nat

iona

l but

no

t int

erna

tion

al c

ontr

ol

(spe

cify

)

__

____

____

____

____

___

__

____

____

____

____

___

__

____

____

____

____

___

Oth

er (s

peci

fy)

__

____

____

____

____

___

a The

“w

hole

sale

leve

l” is

the

leve

l of a

n ill

icit

drug

mar

ket a

t whi

ch th

e dr

ug is

sol

d in

bul

k, to

be

sold

on

to c

onsu

mer

s at

a la

ter s

tage

. b R

epor

t the

mos

t com

mon

val

ues

for p

rice

s an

d pu

ritie

s.

c The

“co

mm

on ra

nge”

is th

e ra

nge

obse

rved

mos

t of t

he ti

me.

For

exa

mpl

e, if

the

pric

e is

bet

wee

n $1

,200

and

$1,

800

mos

t of t

he ti

me,

that

is th

e co

mm

on ra

nge.

d T

he “

reta

il le

vel”

is th

e le

vel o

f an

illic

it dr

ug m

arke

t at w

hich

the

drug

is p

rovi

ded

to c

onsu

mer

s (u

sers

). e F

or c

anna

bis

prod

ucts

, pur

ity re

fers

to te

trah

ydro

cann

abin

ol (

THC

) con

tent

. If y

our c

ount

ry d

oes

not r

outin

ely

mea

sure

the

THC

con

tent

in c

anna

bis

seiz

ures

, lea

ve

the

cann

abis

pur

ity q

uest

ions

bla

nk.

f Fo

r exa

mpl

e, b

row

n or

whi

te h

eroi

n, h

eroi

n N

o. 3

, her

oin

No.

4 e

tc.

g For

opi

um p

rodu

cts,

pur

ity re

fers

to m

orph

ine

cont

ent.

h For

am

phet

amin

e-ty

pe s

timul

ants

in ta

blet

form

, ple

ase

repo

rt th

e w

eigh

t (in

mg)

of t

he q

uant

ity o

f con

trol

led

subs

tanc

e pe

r tab

let (

for e

xam

ple,

30

mg)

.


20 V.10-55614

19.

Wha

t def

initi

on o

f “w

hole

sale

” ha

ve y

ou u

sed

in a

nsw

erin

g th

ese

ques

tions

? If

diff

eren

t def

initi

ons

wer

e us

ed f

or d

iffer

ent d

rugs

, ple

ase

prov

ide

each

def

initi

on s

epar

atel

y, in

dica

ting

whi

ch d

rugs

they

ref

er to

. Whe

re

appl

icab

le,

plea

se i

ndic

ate

whe

ther

the

pur

ity m

easu

rem

ents

inc

lude

the

sal

t pa

rt o

f th

e su

bsta

nce

or n

ot (

in

othe

r w

ords

, whe

ther

the

wei

ght o

f the

ani

on is

incl

uded

or

not.

For

exam

ple,

“he

roin

hyd

roch

lori

de”

inst

ead

of

“her

oin”

). If

they

do

incl

ude

the

salt

part

of t

he s

ubst

ance

, ple

ase

spec

ify

the

salt

(HC

l, su

lfat

e et

c.).

20

. W

hat d

efin

ition

of

“ret

ail”

hav

e yo

u us

ed in

ans

wer

ing

thes

e qu

estio

ns?

If d

iffer

ent d

efin

ition

s w

ere

used

fo

r di

ffer

ent

drug

s, p

leas

e pr

ovid

e ea

ch d

efin

ition

sep

arat

ely,

ind

icat

ing

whi

ch d

rugs

the

y re

fer

to.

Whe

re

appl

icab

le,

plea

se i

ndic

ate

whe

ther

the

pur

ity m

easu

rem

ents

inc

lude

the

sal

t pa

rt o

f th

e su

bsta

nce

or n

ot (

in

othe

r w

ords

, whe

ther

the

wei

ght o

f the

ani

on is

incl

uded

or

not.

For

exam

ple,

“he

roin

hyd

roch

lori

de”

inst

ead

of

“her

oin”

). If

they

do

incl

ude

the

salt

part

of t

he s

ubst

ance

, ple

ase

spec

ify

the

salt

(hyd

roch

lori

de, s

ulfa

te e

tc.).

Met

adat

a W

hat s

ourc

es o

f inf

orm

atio

n (p

ublis

hed

and

unpu

blis

hed)

wer

e re

ferr

ed to

in a

nsw

erin

g th

ese

ques

tions

?

V.10-55614 21


Price and purity

21. If you provided information about purity in answering the questions above, please explain the methodology used.

22. Was there any significant change in the price or purity of any drug trafficked or sold in your country during the past year compared with the previous year? Please explain the reasons for the change. Remember to always specify the name of the drug or drugs involved.

23. What diluents, cutting agents, adulterants and other psychoactive substances are generally found in the different types of drugs seized in your country?

Class and type of drugs Diluentsa/cutting agents Adulterantsb/other psychoactive drugs Example Lactose Caffeine, ketamine Opioids Heroin

Other (specify) ____________________________ Cocaine Salts (cocaine HCl, powder

cocaine)

Cocaine base

“Crack”

Other (specify) ____________________________ Illicit amphetamine-type stimulants

Amphetamine

Methamphetamine

“Ecstasy”-type substances

Other (specify) ____________________________ Sedatives and tranquillisers (specify)

____________________________

22 V.10-55614


Hallucinogens

LSD

Other (specify) ____________________________

Solvents and inhalants (specify) ____________________________Drugs under national but not international control (specify)

____________________________

____________________________

____________________________

Other (specify) ____________________________

a A “diluent” is a cutting agent used to increase the volume and decrease the purity of a substance. b An “adulterant” is a psychoactive substance other than the named substance that can be added intentionally, occur as a contaminant or

result as a by-product during manufacture. Metadata What sources of information (published and unpublished) were referred to in answering these questions?

V.10-55614 23


Illicit drug market overview

24. Please provide an overall contextual description for each of the drug markets of concern in your country. Include information on all aspects, from illicit cultivation, manufacture and trafficking to retail. You may wish to consider the emerging patterns and trends in price, purity, demand and supply, and whether illicit drug markets interact or overlap. Remember to always indicate which drug or drugs are being referred to and the time frame of observed trends.


24 V.10-55614


Persons brought into formal contact with the police and/or the criminal justice system for drug-related offences

Class of drugs Question 25 26

Number of persons brought into formal contact with the police and/or the criminal justice

systema for personal drug-related offencesb in the reporting year

Number of persons brought into formal contact with the police and/or the criminal justice system

for drug traffickingc in the reporting year

Preferred definition of a minor: a person under 18 years of age. Is the definition “under 18 years of age” used?

Yes No If the answer is no, please specify until what age a person is considered a minor:_________________

Preferred definition of a minor: a person under 18 years of age. Is the definition “under 18 years of age” used?

Yes No If the answer is no, please specify until what age a person is considered a minor:__________________

Do data comply with the definition of “personal drug offences” as “offences related to the use or the possession of drugs for personal consumption” (E/CN.7/2010/15/Add.4)?

Yes No If the answer is no, please provide details: _________________________________________

Do data comply with the definition of “drug trafficking” as “drug offences not in connection with personal use” (E/CN.7/2010/15/Add.4)?

Yes No If the answer is no, please provide details: __________________________________________

Total Male Female Adult Minor Total Male Female Adult Minor All illicit drugs Cannabis Illicit opioids Cocaine Illicit amphetamine-type stimulants

Hallucinogens Drugs under national but not international control (specify)

___________________ ___________________ Other (specify) ____________________ a “Persons brought into formal contact with the police and/or the criminal justice system” may include persons suspected, arrested or

cautioned at the national level (United Nations Survey of Crime Trends and Operations of Criminal Justice Systems, 2009). The definition used should be specified in questions 27 and 28. Further information on the type of data recorded should be given in question 29.

b “Personal drug offences” are drug offences related to the use or the possession of drugs for personal consumption (see definition in E/CN.7/2010/15/Add.4).

c “Drug trafficking” refers to drug offences committed not in connection with personal use (see definition in E/CN.7/2010/15/Add.4).

V.10-55614 25


Question 27 28 29

To which of the following do the data reported in question 25 correspond?

To which of the following do the data reported in question 26 correspond?

At which of the following stages of the criminal justice system are data

collected to arrive at the data reported in questions 25 and 26?

Number of persons suspected Number of persons arrested Number of persons cautioned Other (specify)

Number of persons suspected Number of persons arrested Number of persons cautioned Other (specify)

When the offence is reported to the police (“input” statistics)

After the report to the police but before investigation

After investigation (“output” statistics) Uncertain

Number of personal drug offencesa recorded in the reporting year

Number of drug traffickingb offences recorded in the reporting year

a “Personal drug offences” are drug offences related to the use or the possession of drugs for personal consumption (see definition in E/CN.7/2010/15/Add.4).

b “Drug trafficking” refers to drug offences committed not in connection with personal use (see definition in E/CN.7/2010/15/Add.4).

Class and type of drugs Question 30 List the 10 most common citizenships of people recorded for drug trafficking in your

country, from most common to least common. For each drug, report the number of persons of that citizenship recorded for drug trafficking.

Ow

n co

untr

y

Mos

t com

mon

Seco

nd m

ost

com

mon

Thir

d m

ost

com

mon

Four

th m

ost

com

mon

Fift

h m

ost

com

mon

Sixt

h m

ost

com

mon

Seve

nth

mos

t co

mm

on

Eigh

th m

ost

com

mon

Nin

th m

ost

com

mon

Tent

h m

ost

com

mon

All illicit drugs Citizenship Number

Cannabis Citizenship Number

Illicit opioids Citizenship Number

Cocaine type Citizenship Number

Amphetamine-type stimulants

Citizenship Number

Hallucinogens Citizenship Number


Citizenship Number

_________________ Citizenship _________________ Number _________________ Citizenship _________________ Number

26 V.10-55614



Drug trafficking

31. Describe the current situation with regard to drug trafficking groups operating in your country. For example, what are the nationalities of those involved in drug trafficking? What is the structure of such groups operating in your country? Specify the name of the drug or drugs involved.



27V.10-55614

Illic

it c

ultiv

atio

n an

d pr

oduc

tion

Q

uest

ion

32

33

34

35

36

37

38

Wer

e ill

icit

dru

g cr

ops

cult

ivat

ed in

yo

ur c

ount

ry d

urin

g th

e re

port

ing

year

?

Wha

t was

the

tota

l es

tim

ated

are

a un

der

illic

it d

rug

crop

cu

ltiv

atio

na in y

our

coun

try?

Wha

t was

the

tota

l are

a er

adic

ated

du

ring

the

re

port

ing

year

?

Wha

t was

the

tota

l num

ber

of p

lant

s er

adic

ated

du

ring

the

re

port

ing

year

?

Wha

t was

the

tota

l num

ber

of

site

s er

adic

ated

du

ring

the

re

port

ing

year

?

Wha

t was

the

tota

l ar

ea u

nder

illic

it

drug

cro

p cu

ltiv

atio

n af

ter

erad

icat

ion?

b

Wha

t has

bee

n th

e tr

end

wit

h re

gard

to il

licit

dru

g cr

op

cult

ivat

ion

in y

our

coun

try

duri

ng t

he r

epor

ting

yea

r?c

N

o Ye

s A

rea

Uni

t A

rea

Uni

t N

umbe

r N

umbe

r A

rea

Uni

t

Large increase

Some increase Stable Some

decrease Large

decrease Don’t know

Exam

ple

1

50

0 he

ctar

es20

0 he

ctar

es20

0 00

0 20

0 30

0 he

ctar

es

Opi

um

popp

y

Coc

a bu

sh

C

anna

bis

(out

door

s)

C

anna

bis

(ind

oors

)

Oth

er

(spe

cify

)

a “Ill

icit

drug

cro

p cu

ltiva

tion”

refe

rs to

the

culti

vatio

n of

cro

ps u

sed

in th

e pr

oduc

tion

of n

arco

tic d

rugs

and

psy

chot

ropi

c su

bsta

nces

. b

Nor

mal

ly th

is v

alue

sho

uld

equa

l the

diff

eren

ce b

etw

een

the

corr

espo

ndin

g va

lues

in q

uest

ions

33

and

34. I

f not

, ple

ase

expl

ain

in q

uest

ion

44.

c “St

able

” re

fers

to a

n es

timat

ed v

aria

tion

of u

nder

10

per c

ent;

“som

e in

crea

se”

and

“som

e de

crea

se”

refe

r to

an e

stim

ated

var

iatio

n of

bet

wee

n 10

and

25

per c

ent;

“lar

ge

incr

ease

” an

d “l

arge

dec

reas

e” re

fer t

o an

est

imat

ed v

aria

tion

of m

ore

than

25

per c

ent.


28 V.10-55614

Que

stio

n

39

40

41

42

43

W

hat w

as th

e es

tim

ated

yi

eld

per

harv

est?

W

hat i

s th

e ty

pica

l nu

mbe

r of

har

vest

s pe

r ye

ar?

Wha

t was

the

esti

mat

ed

tota

l ann

ual

prod

ucti

on?

Do

the

esti

mat

es in

que

stio

ns 3

9 an

d 41

ref

er to

dry

wei

ght o

r fr

esh

wei

ght?

If p

ossi

ble,

ple

ase

give

ave

rage

moi

stur

e co

nten

t.

Wha

t has

bee

n th

e tr

end

in p

lant

-bas

ed

drug

pro

duct

ion

in y

our

coun

try

duri

ng t

he p

ast y

ear?

a

A

mou

nt

Yie

ld

W

eigh

t U

nit

Fres

h D

ried

Ave

rage

m

oist

ure

cont

ent

Large increase

Some increase

Stable

Some decrease

Large decrease

Don’t know

Exam

ple

1 50

K

g/ha

2

30 0

00

kg

10%

m

oist

ure

Opi

um

Coc

a le

af

Can

nabi

s he

rb

(out

door

s)

Can

nabi

s re

sin

(out

door

s)

Can

nabi

s he

rb

(ind

oors

)

O

ther

(s

peci

fy)

a “St

able

” re

fers

to a

n es

timat

ed v

aria

tion

of u

nder

10

per c

ent;

“som

e in

crea

se”

and

“som

e de

crea

se”

refe

r to

an e

stim

ated

var

iatio

n of

bet

wee

n 10

and

25

per c

ent;

“lar

ge

incr

ease

” an

d “l

arge

dec

reas

e” re

fer t

o an

est

imat

ed v

aria

tion

of m

ore

than

25

per c

ent.

Met

adat

a W

hat s

ourc

es o

f inf

orm

atio

n (p

ublis

hed

and

unpu

blis

hed)

wer

e re

ferr

ed to

in a

nsw

erin

g th

ese

ques

tions

? Pl

ease

pro

vide

a d

etai

led

desc

ript

ion

of th

e m

etho

dolo

gy y

ou u

sed

for t

he a

nnua

l pro

duct

ion

estim

ates

.

V.10-55614 29


Illicit cultivation and production

44. For those narcotics for which a strong increase or decrease in cultivation or production was observed in the past year, briefly state reasons. Also report any other relevant information on illicit drug crop cultivation and drug production that relates to the past year. Specify the name of the plant and/or drug involved.

Question 45 Name the administrative areas where illicit drug crop cultivation takes place. Specify separately

areas of wild growth. Provide a percentage breakdown of cultivation per administrative area (e.g. area A: 20 per cent, area B: 80 per cent). Also specify the main growing season, if relevant.

Illicit drug crop Percentage of area under cultivation Opium poppy

Coca bush

Cannabis (outdoors)

Cannabis (indoors)

Other (specify)

30 V.10-55614


Question 46 47

Were the following methods used during the reporting year to detect the cultivation of illicit drug crops

(including wild growth)?

What are the main methods used to destroy illicit drug crops (including wild growth)?

Drug plant Methods Drug plant Methods Frequencya

Yes No

Nev

er

Som

e-

times

Oft

en

Opium poppy Remote sensing Opium poppy Aerial spraying with herbicide

Ground surveyb Other use of herbicides Other method (specify) Burning Manual destruction Other method (specify)

Coca bush Remote sensing Coca bush Aerial spraying with herbicide


Cannabis plant Remote sensing Cannabis plant Aerial spraying with herbicide


Other (specify) Remote sensing Other (specify) Aerial spraying with herbicide

Ground surveyb Other use of herbicides _____________ Other method (specify) _____________ Burning Manual destruction Other method (specify)

a The term “often” means more than 50 per cent of the time; “sometimes” less than 50 per cent of the time (but not never). b “Ground survey” refers to the detection of illicit drug crop cultivation by conducting field visits.



31V.10-55614

Illic

it m

anuf

actu

re

Q

uest

ion

48

49

50

51

52

53

How

man

y cl

ande

stin

e la

bora

tori

es

wer

e de

tect

ed

duri

ng th

e re

port

ing

year

?a

How

man

y of

th

e la

bora

tori

es

wer

e pr

oduc

ing

mor

e th

an o

nesu

bsta

nce?

Wha

t oth

er

subs

tanc

es(if

any

) wer

e be

ing

prod

uced

in

the

labo

rato

ries

?

For

syn

thet

ic d

rugs

onl

y: in

dica

te t

he p

hase

of

man

ufac

turi

ng r

each

ed w

hen

the

labo

rato

ry w

as

disc

over

ed.b T

he t

otal

num

ber

in e

ach

row

sho

uld

equa

l the

num

ber

of la

bora

tori

es r

epor

ted

in

ques

tion

48

for

each

syn

thet

ic-r

elat

ed s

ubst

ance

.

For

syn

thet

ic d

rugs

onl

y: in

dica

te t

he s

ize

of t

he

clan

dest

ine

labo

rato

ries

det

ecte

d du

ring

the

re

port

ing

year

. The

tot

al n

umbe

r in

eac

h ro

w

shou

ld e

qual

the

num

ber

of la

bora

tori

es w

here

dr

ugs

and

othe

r su

bsta

nces

are

man

ufac

ture

d re

port

ed in

que

stio

n 51

(a)

.

Wha

t ha

s be

en t

he t

rend

w

ith

rega

rd t

o th

e m

anuf

actu

re o

f ea

ch

subs

tanc

e in

the

pas

t ye

ar?c

Lis

t the

pla

nt-

base

d or

sy

nthe

tic

drug

re

late

d en

d-pr

oduc

ts

assu

med

to

have

be

en

man

ufac

ture

d (e

.g. d

rug

inte

rmed

iate

, dr

ug o

r pr

ecur

sor

chem

ical

)

(a) N

umbe

r of

labo

ra-

tori

es w

here

a

subs

tanc

e or

dru

g is

m

anu-

fact

ured

d

(b) N

umbe

r of

la

bora

tori

es

for

refin

ing,

ta

blet

ing,

cu

ttin

g an

d pa

ckag

inge

(c) N

umbe

r of

si

tes

whe

re

equi

pmen

t or

chem

ical

s w

ere

stor

edf

(d) N

umbe

r of

site

s w

here

eq

uipm

ent,

pack

agin

g or

ch

emic

al

was

te w

as

dum

pedg

(a) K

itche

n la

bora

- to

ries

h

(b) O

ther

smal

l-sca

le

labo

rato

ries

i

(c) M

ediu

m-

to-la

rge-

scal

e la

bora

tori

esj

(d)

Indu

stri

al-

scal

e la

bora

tori

esk

Large increase

Some increase

Stable

Some decrease

Large decrease

Don’t know

Exam

ple

subs

tanc

e A

20

2 Su

bsta

nce

B 14

2

1 3

7 4

2 1

a In

clud

e la

bora

tori

es a

t any

pha

se o

f the

man

ufac

turi

ng p

roce

ss. I

f no

illic

it dr

ug m

anuf

actu

re o

ccur

red

in y

our c

ount

ry d

urin

g th

e re

port

ing

year

, wri

te “

none

” in

the

firs

t ce

ll.

b At t

he “

labo

rato

ry o

pera

tiona

l pha

se”

drug

s ar

e be

ing

man

ufac

ture

d.

c “St

able

” re

fers

to a

n es

timat

ed v

aria

tion

of u

nder

10

per c

ent;

“som

e in

crea

se”

and

“som

e de

crea

se”

refe

r to

an e

stim

ated

var

iatio

n of

bet

wee

n 10

and

25

per c

ent;

“lar

ge

incr

ease

” an

d “l

arge

dec

reas

e” re

fer t

o an

est

imat

ed v

aria

tion

of m

ore

than

25

per c

ent.

d At “

synt

hesi

s la

bora

tori

es”

(als

o kn

own

as “

pow

der l

abor

ator

ies”

), sy

nthe

tic d

rugs

, dru

g in

term

edia

tes

and

prec

urso

r che

mic

als

in a

ny fo

rm a

re m

anuf

actu

red

from

pre

curs

or

and

othe

r che

mic

als.

Suc

h la

bora

tori

es m

ay o

r may

not

be

oper

atio

nal a

t the

tim

e of

dis

cove

ry.

e Lab

orat

orie

s de

dica

ted

to r

efin

ing,

tabl

etin

g, c

uttin

g an

d pa

ckag

ing

are

whe

re d

rugs

are

pro

cess

ed b

ut w

here

no

evid

ence

of s

ynth

esis

exi

sts.

MD

MA

pow

der i

s pr

esse

d in

to

tabl

ets,

pow

der o

r liq

uid

met

ham

phet

amin

e is

refi

ned

into

the

crys

tal f

orm

, dru

g po

wde

rs a

re d

ilute

d (“

cut”

) to

incr

ease

bul

k an

d m

axim

ize

prof

its a

nd m

ater

ials

tem

pora

rily

di

sgui

sed

for t

raff

icki

ng p

urpo

ses

are

reco

vere

d (e

.g. f

or c

ocai

ne c

onve

rsio

n). T

here

is n

o ev

iden

ce o

f dru

g sy

nthe

sis

at th

e lo

catio

n.

f A

t site

s w

here

equ

ipm

ent o

r che

mic

als

are

stor

ed th

ere

may

be

som

e or

eve

n al

l the

com

pone

nts

need

ed to

man

ufac

ture

dru

gs, b

ut th

ere

is n

o ev

iden

ce th

at d

rug

synt

hesi

s or

an

y ot

her o

pera

tion

is ta

king

pla

ce.

g Dum

ping

site

s ar

e lo

catio

ns w

here

equ

ipm

ent,

pack

agin

g or

che

mic

al w

aste

from

syn

thes

is la

bora

tori

es h

ave

been

dis

card

ed. H

owev

er, n

o ev

iden

ce e

xist

s th

at d

rug

synt

hesi

s is

taki

ng p

lace

at s

uch

loca

tions

. h

In “

kitc

hen

labo

rato

ries

” on

ly b

asic

equ

ipm

ent a

nd s

impl

e pr

oced

ures

are

use

d. T

ypic

ally

, tho

se o

pera

ting

in s

uch

labo

rato

ries

hav

e a

limite

d or

non

-exi

sten

t kno

wle

dge

of


32 V.10-55614

chem

istr

y an

d si

mpl

y fo

llow

inst

ruct

ions

. Usu

ally

, the

re a

re n

o si

gnif

ican

t sto

res

of p

recu

rsor

s an

d th

e am

ount

of d

rugs

or o

ther

sub

stan

ces

man

ufac

ture

d is

for p

erso

nal u

se

(a ty

pica

l man

ufac

ture

cyc

le fo

r am

phet

amin

e-ty

pe s

timul

ants

wou

ld y

ield

less

than

50

gram

s of

the

subs

tanc

e).

i Pe

ople

ope

ratin

g in

oth

er s

mal

l-sc

ale

labo

rato

ries

hav

e ad

vanc

ed c

hem

ical

kno

wle

dge.

At s

uch

labo

rato

ries

, mor

e co

mpl

ex a

mph

etam

ine-

type

stim

ulan

ts m

ay b

e m

anuf

actu

red.

The

y m

ay b

e of

sim

ilar s

ize

to “

kitc

hen

labo

rato

ries

” bu

t fre

quen

tly e

mpl

oy n

on-i

mpr

ovis

ed e

quip

men

t. Th

ey m

ay a

lso

incl

ude

expe

rim

enta

l lab

orat

orie

s. T

he

amou

nt m

anuf

actu

red

is ty

pica

lly fo

r per

sona

l use

or f

or u

se b

y a

limite

d nu

mbe

r of c

lose

ass

ocia

tes

(a ty

pica

l man

ufac

ture

cyc

le fo

r am

phet

amin

e-ty

pe s

timul

ants

wou

ld

yiel

d le

ss th

an 5

00 g

ram

s of

the

subs

tanc

e).

j M

ediu

m-t

o-la

rge-

scal

e la

bora

tori

es u

se c

omm

erci

ally

ava

ilabl

e st

anda

rd e

quip

men

t and

gla

ssw

are

(in

som

e ca

ses,

cus

tom

-mad

e eq

uipm

ent)

and

may

ope

rate

for l

onge

r pe

riod

s of

tim

e. T

hey

are

not v

ery

mob

ile, m

akin

g it

poss

ible

to re

cove

r pre

curs

or c

hem

ical

s an

d eq

uipm

ent i

n m

any

case

s (i

t is

thes

e ty

pes

of la

bora

tori

es fo

r w

hich

pr

oduc

tion

estim

ates

are

the

mos

t via

ble

and

relia

ble)

. The

am

ount

man

ufac

ture

d at

suc

h si

tes

is p

rim

arily

for i

llici

t eco

nom

ic g

ain

(a ty

pica

l man

ufac

ture

cyc

le fo

r am

phet

amin

e-ty

pe s

timul

ants

wou

ld y

ield

bet

wee

n 0.

5 kg

and

50

kg o

f the

sub

stan

ce).

k

Indu

stri

al-s

cale

labo

rato

ries

use

ove

rsiz

ed e

quip

men

t and

gla

ssw

are

that

is e

ither

cus

tom

-mad

e or

pur

chas

ed fr

om in

dust

rial

pro

cess

ing

sour

ces.

Suc

h in

dust

rial

ope

ratio

ns

prod

uce

sign

ific

ant a

mou

nts

of a

mph

etam

ine-

type

stim

ulan

ts in

ver

y sh

ort p

erio

ds o

f tim

e, th

e am

ount

bei

ng li

mite

d on

ly b

y ac

cess

to p

recu

rsor

s, re

agen

ts a

nd c

onsu

mab

les

in a

dequ

ate

quan

titie

s an

d th

e lo

gist

ics

and

man

pow

er to

han

dle

larg

e am

ount

s of

dru

gs o

r che

mic

als

and

proc

ess

them

into

the

next

ste

p (a

typi

cal m

anuf

actu

re c

ycle

for

amph

etam

ine-

type

stim

ulan

ts w

ould

yie

ld 5

0 kg

or m

ore)

.


33V.10-55614

Que

stio

n

54

55

W

hat a

re th

e m

ain

type

s of

cla

ndes

tine

labo

rato

ry th

at w

ere

dete

cted

in th

e re

port

ing

year

? W

here

are

cla

ndes

tine

labo

rato

ries

mai

nly

loca

ted?

Spe

cify

adm

inis

trat

ive

area

s an

d ge

nera

l loc

atio

n (e

.g. n

orth

, sou

th, c

entr

e) w

here

man

ufac

ture

ta

kes

plac

e.

Freq

uenc

ya

Subs

tanc

e pr

oduc

ed

Type

of l

abor

ator

y N

ever

So

me-

ti

mes

O

ften

M

obile

labo

rato

ry

O

n pr

ivat

e pr

emis

es

In

indu

stri

al/c

omm

erci

al fa

cilit

ies

____

____

____

____

_ In

uni

vers

ities

/res

earc

h in

stitu

tes

O

ther

(spe

cify

)

Mob

ile la

bora

tory

On

priv

ate

prem

ises

In in

dust

rial

/com

mer

cial

faci

litie

s

__

____

____

____

___

In u

nive

rsiti

es/r

esea

rch

inst

itute

s

Oth

er (s

peci

fy)

M

obile

labo

rato

ry

O

n pr

ivat

e pr

emis

es

In

indu

stri

al/c

omm

erci

al fa

cilit

ies

____

____

____

____

_ In

uni

vers

ities

/res

earc

h in

stitu

tes

O

ther

(spe

cify

)

Mob

ile la

bora

tory

On

priv

ate

prem

ises

In in

dust

rial

/com

mer

cial

faci

litie

s

__

____

____

____

___

In u

nive

rsiti

es/r

esea

rch

inst

itute

s

Oth

er (s

peci

fy)

M

obile

labo

rato

ry

O

n pr

ivat

e pr

emis

es

In

indu

stri

al/c

omm

erci

al fa

cilit

ies

____

____

____

____

_ In

uni

vers

ities

/res

earc

h in

stitu

tes

O

ther

(spe

cify

)

a The

term

“of

ten”

mea

ns m

ore

than

50

per c

ent o

f the

tim

e; “

som

etim

es”

less

than

50

per c

ent o

f the

tim

e (b

ut n

ot n

ever

). M

etad

ata

Wha

t sou

rces

of i

nfor

mat

ion

(pub

lishe

d an

d un

publ

ishe

d) w

ere

refe

rred

to in

ans

wer

ing

thes

e qu

estio

ns?

34 V.10-55614


Clandestine laboratories

56. In the space provided below, provide information about no more than eight seizures carried out at clandestine laboratories during the reporting period. If the number of seizures that took place in your country is more than eight, provide information about seizures that illustrate common practices or that highlight emerging trends in illicit drug production and manufacture.

For each seizure, provide at least the following information, if available:

• Name of drug or end product manufactured

• Type of laboratory (e.g. if for processing, manufacture, tableting etc.)

• Volume and extent of drug manufacture (e.g. period of operation, amount manufactured during the period of operation, estimated production capacity)

• Methods, processes, routes of illicit manufacture

• For tableting laboratories: please describe any tablet marks or logos used and estimate the capacity of the tableting equipment

• Operational status of laboratory at the time of seizure (e.g. active, abandoned)

Seizure 1. Name of drug or end product manufactured:




V.10-55614 35








36 V.10-55614

Illic

it m

anuf

actu

re

Que

stio

n 57

58

59

W

hich

mat

eria

ls a

re u

sed

in th

e pr

oduc

tion

of p

lant

-bas

ed d

rugs

in y

our

coun

try

and

wha

t are

th

e co

nver

sion

rat

es e

ncou

nter

ed?

(a) W

hat

is t

he

plan

t-ba

sed

drug

(e

nd p

rodu

ct)?

(b) W

hat r

aw

mat

eria

ls a

re u

sed

to

prod

uce

the

end

prod

uct?

a

(c) W

hat i

s th

e m

oist

ure

cont

ent

(e.g

. 70

per

cent

, dr

y) o

f th

e ra

w m

ater

ial

(if

appl

icab

le)?

(d) W

hat

quan

tity

of

raw

mat

eria

l is

use

d to

pro

duce

1 k

g of

end

pr

oduc

t?

Wha

t ar

e th

e m

ain

coun

trie

s of

ori

gin

of t

he r

aw m

ater

ial

used

?

Wha

t pe

rcen

tage

of

the

tota

l qua

ntit

y of

dru

gs

prod

uced

is d

esti

ned

for

dom

esti

c co

nsum

ptio

n an

d w

hat

perc

enta

ge is

des

tine

d fo

r tr

affi

ckin

g ab

road

?

Qua

ntit

y U

nit

D

omes

tic

cons

umpt

ion

Tr

affi

ckin

g ab

road

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

a Coc

a le

af, o

pium

pop

py, p

oppy

str

aw e

tc.

Plea

se e

xpla

in th

e cr

iteri

a us

ed to

ans

wer

que

stio

n 59

:

M

etad

ata

Wha

t sou

rces

of i

nfor

mat

ion

(pub

lishe

d an

d un

publ

ishe

d) w

ere

refe

rred

to in

ans

wer

ing

thes

e qu

estio

ns?


37V.10-55614

Illic

it m

anuf

actu

re

Que

stio

n 60

61

W

hat p

recu

rsor

che

mic

als

are

used

in t

he m

anuf

actu

re o

f syn

thet

ic d

rugs

in y

our

coun

try

and

wha

t are

the

conv

ersi

on r

ates

enc

ount

ered

? W

hat p

erce

ntag

e of

the

tota

l end

pro

duct

is d

esti

ned

for

dom

esti

c co

nsum

ptio

n an

d w

hat p

erce

ntag

e is

des

tine

d fo

r tr

affi

ckin

g ab

road

? (a

) Wha

t is

the

en

d pr

oduc

t (s

ynth

etic

dru

g)?

(b) W

hat i

s th

e pr

imar

y pr

ecur

sor

chem

ical

use

d to

man

ufac

ture

the

end

pr

oduc

t?

(c) W

hat

perc

enta

ge o

f la

bora

tori

es u

se

this

pre

curs

or

chem

ical

?

(d) W

hat

quan

tity

of

this

pr

ecur

sor

chem

ical

is u

sed

to

prod

uce

1 kg

of

end

prod

uct?

Q

uant

ity

Uni

t E

nd-p

rodu

ct

(syn

thet

ic d

rug)

D

omes

tic

cons

umpt

ion

Traf

fick

ing

abro

ad

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

+

=10

0%

Plea

se e

xpla

in th

e cr

iteri

a us

ed to

use

d to

ans

wer

que

stio

n 61

:


38 V.10-55614

Que

stio

n

62

63

64

End

pro

duct

(s

ynth

etic

dru

g)

(cop

y fr

om

abov

e)

Wha

t oth

er e

ssen

tial

che

mic

als

(rea

gent

s)

are

used

to m

anuf

actu

re th

e en

d pr

oduc

t?

Wha

t qua

ntit

y of

thes

e ot

her

chem

ical

s is

us

ed to

pro

duce

1 k

g of

end

pro

duct

? W

hat i

s th

e ty

pica

l illi

cit (

blac

k m

arke

t) v

alue

of 1

kg

of th

e pr

imar

y pr

ecur

sor

chem

ical

?

Pr

ice

Cur

renc

y Q

uant

ity

Met

adat

a

Wha

t sou

rces

of i

nfor

mat

ion

(pub

lishe

d an

d un

publ

ishe

d) w

ere

refe

rred

to in

ans

wer

ing

thes

e qu

estio

ns?

V.10-55614 39


65. Describe any other information relevant to the illicit manufacture of drugs or precursor chemicals in your country. For drugs where a strong increase or decrease in illicit manufacture was indicated in question 52, briefly state the reasons. Specify the name of the drug or drugs involved.


40 V.10-55614


Diversion from licit channels

Question 66 67 68

Which licit drugs have been diverted from licit channels in your country,

during the reporting year?

How many cases of diversion were recorded in the reporting year?

What is the total quantity of drugs diverted in the reporting period?

Quantity Unit

Question 69

What are the main methods used to divert licit drugs in your country? For each drug diverted, select no more than three main methods by writing the numbers 1, 2 and 3 next to the methods listed below. Drug diverted Main methods of diversion (select no more than three) ________________________

Theft from factory or wholesaler Forgery of prescriptions Diversion from international trade Theft from pharmacies Obtained through friends or family

Sales of prescriptions to unauthorized persons Theft from hospitals or doctors’ offices Other diversion by medical professionals Other (specify) _________________________

________________________



________________________



________________________



________________________



________________________



V.10-55614 41


Metadata What sources of information (published and unpublished) were referred to in answering questions 66-69 on the previous page?

42 V.10-55614


Additional comments

Use the space below to make notes and comments, to clarify any of the information contained in this questionnaire and to document any other issues that you wish to draw to the attention of UNODC. If your comment relates to a specific question in the questionnaire, please refer to the corresponding question number.

UNODC/CND/EG.1/2010/13 28 July 2010 Original: English Item ...€¦ · Vienna, 11-13 October 2010...

Documents

Transcript of UNODC/CND/EG.1/2010/13 28 July 2010 Original: English Item ...€¦ · Vienna, 11-13 October 2010...